Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01879641
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.76 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.73 | |
RO4 | [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL- BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER | A | 2TCL | 0.77 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.76 | |
UZ9 | (2S)-2-AMINO-6-({(4R)-4-[(10R,13S)- 10,13-DIMETHYL-3-OXOHEXADECAHYDRO- 1H-CYCLOPENTA[A]PHENANTHREN-17- YL]PENTANOYL}AMINO)HEXANOIC ACID | A,B | 1UZ9 | 0.71 | |
TRL | {1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO- PYRROLIDINE-1-CARBONYL]-2-METHYL- PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER | A,B | 1N1L | 0.71 | |
TCO | TERT-BUTYL(1S)-1-CYCLOHEXYL-2-OXOETHYLCARBAMATE | A | 1Q6K | 0.76 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.72 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.77 | |
HU1 | TERT-BUTYL {(1S)-2-[(1R,2S,5S)- 2-({[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)- 2,3-DIOXOPROPYL]AMINO}CARBONYL)- 6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX- 3-YL]-1-CYCLOHEXYL-2-OXOETHYL}CARBAMATE | A,C | 2OC0 | 0.73 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.73 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CAY | 0.72 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CBA | 0.72 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.75 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.75 | |
BEQ | N-(CARBOXYMETHYL)-N,N-DIMETHYL- 3-[(1-OXODODECYL)AMINO]-1-PROPANAMINIUM INNER SALT | A,B,C,D | 1YBK | 0.71 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.77 | |
CIB | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1- (1-FORMYL-PENTYLCARBAMOYL)-3-METHYL- BUTYL]-AMIDE | H,I,J,K,L,M,N | 1J2Q | 0.71 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.74 | |
IGN | {[(1R)-2-((2S)-2-{[(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)AMINO]CARBONYL}PIPERIDINYL)- 1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]AMINO}ACETIC ACID | A | 1K1O | 0.76 | |
IGN | {[(1R)-2-((2S)-2-{[(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)AMINO]CARBONYL}PIPERIDINYL)- 1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]AMINO}ACETIC ACID | H,I | 1K21 | 0.76 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.73 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAG | 0.7 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAF | 0.7 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A,B,C,D | 3FMF | 0.7 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAI | 0.7 | |
HUD | TERT-BUTYL [(1S)-1-{[(1R,2S,5S)- 2-({[(1S)-3-AMINO-1-(CYCLOPROPYLMETHYL)- 2,3-DIOXOPROPYL]AMINO}CARBONYL)- 6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX- 3-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE | A,C | 2OBO | 0.73 | |
MNL | 4,N-DIMETHYLNORLEUCINE | C | 1CWC | 0.71 | |
140 | N-PALMITOYLGLYCINE | A,B | 1JPZ | 0.74 | |
140 | N-PALMITOYLGLYCINE | A,B | 1ZOA | 0.74 | |
140 | N-PALMITOYLGLYCINE | A,B | 3CBD | 0.74 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.73 | |
LBY | N~6~-(TERT-BUTOXYCARBONYL)-L-LYSINE | A | 2ZIN | 0.76 |